Madlaina Breuleux

712 total citations
13 papers, 486 citations indexed

About

Madlaina Breuleux is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Madlaina Breuleux has authored 13 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Genetics and 4 papers in Oncology. Recurrent topics in Madlaina Breuleux's work include Chronic Lymphocytic Leukemia Research (6 papers), Advanced Breast Cancer Therapies (3 papers) and 14-3-3 protein interactions (3 papers). Madlaina Breuleux is often cited by papers focused on Chronic Lymphocytic Leukemia Research (6 papers), Advanced Breast Cancer Therapies (3 papers) and 14-3-3 protein interactions (3 papers). Madlaina Breuleux collaborates with scholars based in Switzerland, United States and Australia. Madlaina Breuleux's co-authors include Heidi A. Lane, Christine Stephan, David J. Kwiatkowski, Saveur-Michel Maira, Cheryl A. Doughty, Louise Barys, Cathrin Brisken, Markus Wartmann, Anne Boulay and Maryse Fiche and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Madlaina Breuleux

13 papers receiving 483 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Madlaina Breuleux Switzerland 8 323 154 79 66 66 13 486
Kathryn M. Kinross Australia 9 409 1.3× 158 1.0× 77 1.0× 77 1.2× 88 1.3× 16 632
Vivekananda Sarangi United States 13 188 0.6× 191 1.2× 69 0.9× 91 1.4× 81 1.2× 25 469
Anja Kafka Croatia 13 315 1.0× 120 0.8× 77 1.0× 76 1.2× 125 1.9× 24 536
Liping Chung Australia 14 270 0.8× 158 1.0× 93 1.2× 60 0.9× 119 1.8× 20 555
Patricia S. Hähnel Germany 10 297 0.9× 152 1.0× 27 0.3× 64 1.0× 58 0.9× 13 513
Abbey L. Wentzel United States 9 335 1.0× 344 2.2× 84 1.1× 63 1.0× 95 1.4× 10 568
Byung–Kyu Ryu South Korea 10 374 1.2× 135 0.9× 62 0.8× 66 1.0× 120 1.8× 11 562
Margarite D. Matossian United States 14 314 1.0× 258 1.7× 50 0.6× 29 0.4× 136 2.1× 39 588
BaoHan T. Vo United States 12 335 1.0× 114 0.7× 77 1.0× 18 0.3× 107 1.6× 15 502
Jae Hwi Song South Korea 16 388 1.2× 131 0.9× 56 0.7× 52 0.8× 89 1.3× 27 568

Countries citing papers authored by Madlaina Breuleux

Since Specialization
Citations

This map shows the geographic impact of Madlaina Breuleux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Madlaina Breuleux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Madlaina Breuleux more than expected).

Fields of papers citing papers by Madlaina Breuleux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Madlaina Breuleux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Madlaina Breuleux. The network helps show where Madlaina Breuleux may publish in the future.

Co-authorship network of co-authors of Madlaina Breuleux

This figure shows the co-authorship network connecting the top 25 collaborators of Madlaina Breuleux. A scholar is included among the top collaborators of Madlaina Breuleux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Madlaina Breuleux. Madlaina Breuleux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Fraser, Graeme, Brian Leber, Reinhard Marks, et al.. (2019). PS1161 EFFICACY AND SAFETY OF IBRUTINIB IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS PREVIOUSLY TREATED WITH VENETOCLAX IN THE MURANO STUDY. HemaSphere. 3(S1). 527–527. 2 indexed citations
2.
Brown, Jennifer R., Matthew S. Davids, Julie Chang, et al.. (2019). Outcomes of Ibrutinib (Ibr) Therapy in Ibr-Naïve Patients (pts) with Chronic Lymphocytic Leukemia (CLL) Progressing after Venetoclax (Ven). Blood. 134(Supplement_1). 4320–4320. 7 indexed citations
3.
4.
Cochrane, Tara, Tatiana Chagorova, Tadeusz Robak, et al.. (2018). Venetoclax Improves Quality of Life for Patients with Elapsed/Refractory Chronic Lymphocytic Leukemia. Blood. 132(Supplement 1). 4858–4858. 3 indexed citations
5.
Wierda, William G., Andrew W. Roberts, Paolo Ghia, et al.. (2018). Minimal Residual Disease Status with Venetoclax Monotherapy Is Associated with Progression-Free Survival in Chronic Lymphocytic Leukemia. Blood. 132(Supplement 1). 3134–3134. 5 indexed citations
6.
Salles, Gilles, Stephen J. Schuster, Sven de Vos, et al.. (2015). Idelalisib efficacy and safety in follicular lymphoma patients from a phase 2 study.. Journal of Clinical Oncology. 33(15_suppl). 8529–8529. 5 indexed citations
7.
Breuleux, Madlaina, Christine Stephan, Cheryl A. Doughty, et al.. (2009). Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition. Molecular Cancer Therapeutics. 8(4). 742–753. 181 indexed citations
8.
Lane, Heidi A. & Madlaina Breuleux. (2009). Optimal targeting of the mTORC1 kinase in human cancer. Current Opinion in Cell Biology. 21(2). 219–229. 67 indexed citations
9.
Breuleux, Madlaina, et al.. (2009). BAL27862: A Unique Microtubule Destabilizer Active Against Chemorefractory Breast Cancers.. Cancer Research. 69(24_Supplement). 2093–2093. 2 indexed citations
10.
Boulay, Anne, Madlaina Breuleux, Christine Stephan, et al.. (2008). The Ret Receptor Tyrosine Kinase Pathway Functionally Interacts with the ERα Pathway in Breast Cancer. Cancer Research. 68(10). 3743–3751. 92 indexed citations
11.
Fragkos, Michalis, Madlaina Breuleux, Nathalie Clément, & Peter Beard. (2008). Recombinant Adeno-Associated Viral Vectors Are Deficient in Provoking a DNA Damage Response. Journal of Virology. 82(15). 7379–7387. 32 indexed citations
12.
Breuleux, Madlaina. (2007). Role of heregulin in human cancer. Cellular and Molecular Life Sciences. 64(18). 2358–2377. 67 indexed citations
13.
Breuleux, Madlaina, et al.. (2006). Heregulins Implicated in Cellular Functions Other Than Receptor Activation. Molecular Cancer Research. 4(1). 27–37. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathryn M. Kinross Breakdown of academic impact, for papers by Vivekananda Sarangi Breakdown of academic impact, for papers by Anja Kafka Breakdown of academic impact, for papers by Liping Chung Breakdown of academic impact, for papers by Patricia S. Hähnel Breakdown of academic impact, for papers by Abbey L. Wentzel Breakdown of academic impact, for papers by Byung–Kyu Ryu Breakdown of academic impact, for papers by Margarite D. Matossian Breakdown of academic impact, for papers by BaoHan T. Vo Breakdown of academic impact, for papers by Jae Hwi Song
Rankless by CCL
2026